Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).
Mr. Joaquin Duato 2016 'den beri şirketle birlikte olan Johnson & Johnson 'in Chairman of the Board 'ıdır.
JNJ hissesinin fiyat performansı nasıl?
JNJ 'in mevcut fiyatı $241.23 'dir, son işlem günde 2.53% arttırılmış etti.
Johnson & Johnson için ana iş temaları veya sektörler nelerdir?
Johnson & Johnson Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Johnson & Johnson 'in piyasa değerlemesi nedir?
Johnson & Johnson 'in mevcut piyasa değerlemesi $581.3B 'dir
Johnson & Johnson al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 29 analist Johnson & Johnson için analist derecelendirmeleri gerçekleştirdi, bunlar 5 güçlü al, 11 al, 15 tut, 0 sat ve 5 güçlü sat içermektedir
